Healthcare Industry Today
SEE OTHER BRANDS

Exploring the healthcare news of the world

Healthcare Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Industry Today.

Press releases published on August 1, 2025

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten …

Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic …

Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion

Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion

Funds will support advancement of Tevogen.AI, the Company’s artificial intelligence–driven drug discovery initiative. The $1 million is part of up to $10 million in previously announced non‑dilutive grant funding from KRHP LLC. WARREN, N.J., Aug. 01, 2025 …

As the $420B Cold Chain Booms, Ergodyne Arms the Front Lines

As the $420B Cold Chain Booms, Ergodyne Arms the Front Lines

St. Paul, MN, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Cold chain logistics is one of the fastest-growing industries in the world, projected to top $420 billion this year alone. That surge comes with rising demand for product, speed, and increasingly, gear that …

Sutter Health Showcases Groundbreaking Research at Symposium, Advancing Clinical Innovations to Deliver Real-World Solutions

Sutter Health Showcases Groundbreaking Research at Symposium, Advancing Clinical Innovations to Deliver Real-World Solutions

NORTHERN CALIF., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nearly 500 physicians, researchers, academic collaborators, medical students, residents, fellows and clinical leaders from across Sutter Health’s integrated system are gathering in Sacramento today for the …

Global Outpatient Clinics Market Sees Shift Toward Tech-Driven Patient Care

Global Outpatient Clinics Market Sees Shift Toward Tech-Driven Patient Care

Boston, Aug. 01, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Global Outpatient Clinics Market” is expected to grow from $4.4 trillion in 2024 to $6.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of …

Pheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors

Pheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors

BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company,” “we,” “our” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today …

Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures

Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures

CARLSBAD, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient Prospective Payment Systems Final Rule …

IPG Health Introduces the Future of Market Research with ‘LivingMirror,’ an Always-On AI Focus Group for Healthcare

IPG Health Introduces the Future of Market Research with ‘LivingMirror,’ an Always-On AI Focus Group for Healthcare

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- For decades, market research has laid the foundation for deep insights around the globe helping brands connect, understand and grow. Now with the ability to combine agentic AI with robust data-driven audience …

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives

HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the appointment of Justin Van Fleet, CPA, …

Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer

Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer

ROSELAND, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Eric C. Hines as Chief …

IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results

IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results

Announces Regular Quarterly Cash Dividend of $0.17 Per Share Raises Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $20.4 million for the second quarter of 2025, an increase of $2.5 million, or 14%, compared to the same period in …

Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma

Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma

Lymphodepletion Regimen Selection Made in Conjunction with the ALPHA3 Data and Safety Monitoring Board (DSMB) and Steering Committee, and in Consultation with the FDA Following an ALLO-647-Related Death in the FCA (FC plus ALLO-647) Lymphodepletion Arm …

Ocugen Provides Business Update with Second Quarter 2025 Financial Results

Ocugen Provides Business Update with Second Quarter 2025 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET Initiated dosing in OCU410ST Phase 2/3 GARDian3 pivotal confirmatory clinical trial Actively dosing patients in OCU400 Phase 3 liMeliGhT clinical trial and on track for 2026 BLA filing OrthoCellix reverse …

OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case

OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case

WARSAW, Ind., Aug. 01, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the US launch and first surgical case …

I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares

I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares

ROCKVILLE, Md., Aug. 01, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced the pricing of an …

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CHARLESTOWN, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 55,450 restricted …

Ascentage Pharma to Participate in Evercore China Biotech Summit

Ascentage Pharma to Participate in Evercore China Biotech Summit

ROCKVILLE, Md. and SUZHOU, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in …

Legend Senior Living Expands Management Team, Naming Brian Donnelly as Director of Dining Experience

Legend Senior Living Expands Management Team, Naming Brian Donnelly as Director of Dining Experience

WICHITA, Kan., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a nationally recognized senior living provider which operates over seventy residences in six states, has expanded its management team by adding Brian Donnelly as the new Director of …

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement

LANGHORNE, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions